WindMIL Therapeutics is a clinical stage oncology cell therapy company. The company is leveraging its proprietary platform to develop a novel class of cell therapies called MILs™ (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow.

Biotechnology

WindMIL Therapeutics

WindMIL Therapeutics' headquarters in Baltimore, MD, United States

The Scientific Advisors team at WindMIL Therapeutics plays a critical role in guiding the research and development of innovative oncology cell therapies. This team comprises experts who provide strategic insights, evaluate scientific data, and collaborate with cross-functional groups to advance the understanding and clinical application of MILs™ (Marrow Infiltrating Lymphocytes), ensuring the company remains at the forefront of therapeutic advancements in oncology.

Scientific Advisors

The Leadership Team at WindMIL Therapeutics guides the strategic vision and operational execution of the company, driving the development of innovative cell therapies. Comprising key executives with expertise in corporate development, scientific oversight, regulatory affairs, and quality systems, this team oversees clinical programs, fosters partnerships, and ensures compliance with industry standards to advance the company’s mission in oncology.

��

People (6)

Jobs (0)

Other teams

Leadership Team

��������

People (6)

Jobs (0)

Other teams

Leadership Team

��